Skeel A, Leonard E J
Immunopathology Section, Laboratory of Immunobiology, NCI-Frederick Cancer Research and Development Center, Frederick, Maryland 21702, USA.
J Biol Chem. 2001 Jun 15;276(24):21932-7. doi: 10.1074/jbc.M100652200. Epub 2001 Mar 23.
Macrophage stimulating protein (MSP) is secreted as 78-kDa single chain pro-MSP, which is converted to biologically active, disulfide-linked alphabeta chain MSP by cleavage at Arg(483)-Val(484). Murine resident peritoneal macrophages have two cell surface proteolytic activities that cleave pro-MSP. One is a pro-MSP convertase, which cleaves pro-MSP to active MSP; the other degrades pro-MSP. The degrading protease is inhibited by soybean trypsin inhibitor or by low concentrations of blood plasma, which allows the convertase to cleave pro-MSP to MSP. Using pro-MSP cleavage as the assay, we purified the inhibitor from human plasma. The bulk of the plasma protein was removed by salting out and by isoelectric precipitation of albumin. Highly purified inhibitor was then obtained in three steps: dye-ligand binding and elution, ion exchange chromatography, and high performance liquid chromatography gel filtration. After SDS-polyacrylamide gel electrophoresis and transfer to a polyvinylidene membrane, N-terminal sequencing of the product identified it as alpha(1)-antichymotrypsin. The mean concentration of alpha(1)-antichymotrypsin in human plasma is 7 micrometer. At this concentration, alpha(1)-antichymotrypsin inhibits both macrophage enzymes. A concentration of 0.4 micrometer, which is in the expected concentration range in extracellular fluid, preferentially inhibits the degrading enzyme, which allows for cleavage to active MSP by the pro-MSP convertase.
巨噬细胞刺激蛋白(MSP)以78 kDa的单链前体MSP形式分泌,通过在精氨酸(483)-缬氨酸(484)处切割,转化为具有生物活性的、二硫键连接的αβ链MSP。小鼠驻留腹膜巨噬细胞具有两种切割前体MSP的细胞表面蛋白水解活性。一种是前体MSP转化酶,它将前体MSP切割为活性MSP;另一种则降解前体MSP。降解蛋白酶可被大豆胰蛋白酶抑制剂或低浓度血浆抑制,这使得转化酶能够将前体MSP切割为MSP。以前体MSP切割作为检测方法,我们从人血浆中纯化了该抑制剂。通过盐析和白蛋白的等电沉淀去除了大部分血浆蛋白。然后通过三步获得了高度纯化的抑制剂:染料配体结合与洗脱、离子交换色谱和高效液相色谱凝胶过滤。经十二烷基硫酸钠-聚丙烯酰胺凝胶电泳并转移至聚偏二氟乙烯膜后对产物进行N端测序鉴定其为α(1)-抗糜蛋白酶。人血浆中α(1)-抗糜蛋白酶的平均浓度为7微摩尔。在此浓度下,α(1)-抗糜蛋白酶可抑制两种巨噬细胞酶。细胞外液中预期浓度范围的0.4微摩尔浓度优先抑制降解酶,从而使前体MSP转化酶能够将其切割为活性MSP。